Absci Corp (ABSI)
4.21
-0.04
(-0.94%)
USD |
NASDAQ |
May 31, 16:00
4.19
-0.02
(-0.48%)
After-Hours: 20:00
Absci Cash from Operations (Annual): -64.64M for Dec. 31, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -64.64M |
| December 31, 2022 | -81.34M |
| December 31, 2021 | -60.60M |
| Date | Value |
|---|---|
| December 31, 2020 | -10.97M |
| December 31, 2019 | -6.032M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
-81.34M
Minimum
2022
-6.032M
Maximum
2019
-44.72M
Average
-60.60M
Median
2021
Cash from Operations (Annual) Benchmarks
| Eli Lilly and Co | 4.240B |
| Creative Medical Technology Holdings Inc | -8.028M |
| CytomX Therapeutics Inc | -56.04M |
| Bristol-Myers Squibb Co | 13.86B |
| Recursion Pharmaceuticals Inc | -287.78M |